Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results
Clinical Cardiology
- Dapagliflozin
- Heart failure with reduced ejection fraction
- KCCQ-23
- Left ventricular ejection fraction
- Myocardial infarction
- Humans
The paper
Potoupni V, Boulmpou A, Maragkoudakis S et al.
Clinical Cardiology · 1 Sep 2026